- Former Keurig President -
BOSTON--(BUSINESS WIRE)--Mar. 7, 2016--
Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing
innovative and proprietary treatments for nocturnal leg cramps (NLC),
spasms associated with severe neuromuscular
conditions, and exercise-associated muscle cramps, announced today that
Michelle V. Stacy, former President of Keurig Inc., has joined its Board
As the former president of Keurig, Inc. and former vice president and
general manager with Gillette/P&G, Ms. Stacy brings a wealth of
experience leading consumer businesses and building global brands.
During her five-year tenure at Keurig Inc., a division of Keurig Green
Mountain, the company's revenue grew from $493 million in FY2008 to $4.3
billion for FY2013. Ms. Stacy also sits on the Board of Directors of
iRobot Corp, Coravin Inc. and Young Innovations Inc.; is a Director
Advisor to The Cambridge Group (an AC Nielson Company); and is a
professional speaker on leadership, innovation and growth. She received
her M.S. in Management from J. L. Kellogg Graduate School of Management
- Northwestern University, her B.S. from Dartmouth College.
Ms. Stacy noted, “I look forward to leveraging my extensive consumer
background to help Flex Pharma’s emerging consumer product grow into a
significant global brand.”
“Ms. Stacy represents Flex Pharma’s continuing ability to attract top
talent based on its unique growth opportunities on both the consumer and
drug development arms of the business,” said John Sculley, former CEO of
Pepsi and Apple and Flex Pharma Board member and investor.
About Flex Pharma
Flex Pharma, Inc. is a biotechnology company that is developing
innovative and proprietary treatments for nocturnal leg cramps, spasms
associated with severe neuromuscular conditions such as ALS and
MS, and exercise-associated muscle cramps. Flex Pharma was founded by
National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel
Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of
ion channels and neurobiology, along with Chair and CEO Christoph
Westphal, M.D., Ph.D.
Follow Flex Pharma on twitter (@flexpharma) and visit the Company’s
web site (http://ir.flex-pharma.com/) for
updates of the Company's pre-launch activities for its
consumer product to prevent and treat exercise-associated muscle cramps.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160307006487/en/
Source: Flex Pharma, Inc.
Flex Pharma, Inc.
Elizabeth Woo, 617-874-1829
Relations & Corporate Communications